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Abstract: Bone regeneration is a complex process and the clinical translation of tissue engineered con-
structs (TECs) remains a challenge. The combination of biomaterials and mesenchymal stem cells (MSCs)
may enhance the healing process through paracrine effects. Here, we investigated the influence of cell
format in combination with a collagen scaffold on key factors in bone healing process, such as mineral-
ization, cell infiltration, vascularization, and ECM production. MSCs as single cells (2D-SCs), assembled
into microtissues (3D-MTs) or their corresponding secretomes were combined with a collagen scaffold
and incubated on the chicken embryo chorioallantoic membrane (CAM) for 7 days. A comprehensive
quantitative analysis was performed on a cellular level by histology and by microcomputed tomography
(microCT). In all experimental groups, accumulation of collagen and glycosaminoglycan within the scaf-
fold was observed over time. A pronounced cell infiltration and vascularization from the interface to the
surface region of the CAM was detected. The 3D-MT secretome showed a significant mineralization of
the biomaterial using microCT compared to all other conditions. Furthermore, it revealed a homogeneous
distribution pattern of mineralization deposits in contrast to the cell-based scaffolds, where mineraliza-
tion was only at the surface. Therefore, the secretome of MSCs assembled into 3D-MTs may represent
an interesting therapeutic strategy for a next-generation bone healing concept.
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3D‑microtissue derived 
secretome as a cell‑free approach 
for enhanced mineralization 
of scaffolds in the chorioallantoic 
membrane model
Lukas Otto1,2,11, Petra Wolint1,2,11, Annina Bopp3,4, Anna Woloszyk3,5, Anton S. Becker6, 
Andreas Boss6, Roland Böni7, Maurizio Calcagni1,2, Pietro Giovanoli1,2, Simon P. Hoerstrup3,8, 
Maximilian Y. Emmert3,8,9,10,12* & Johanna Buschmann1,2,12*
Bone regeneration is a complex process and the clinical translation of tissue engineered constructs 
(TECs) remains a challenge. The combination of biomaterials and mesenchymal stem cells (MSCs) 
may enhance the healing process through paracrine effects. Here, we investigated the influence 
of cell format in combination with a collagen scaffold on key factors in bone healing process, such 
as mineralization, cell infiltration, vascularization, and ECM production. MSCs as single cells (2D‑
SCs), assembled into microtissues (3D‑MTs) or their corresponding secretomes were combined 
with a collagen scaffold and incubated on the chicken embryo chorioallantoic membrane (CAM) for 
7 days. A comprehensive quantitative analysis was performed on a cellular level by histology and 
by microcomputed tomography (microCT). In all experimental groups, accumulation of collagen 
and glycosaminoglycan within the scaffold was observed over time. A pronounced cell infiltration 
and vascularization from the interface to the surface region of the CAM was detected. The 3D‑MT 
secretome showed a significant mineralization of the biomaterial using microCT compared to all other 
conditions. Furthermore, it revealed a homogeneous distribution pattern of mineralization deposits 
in contrast to the cell‑based scaffolds, where mineralization was only at the surface. Therefore, the 
secretome of MSCs assembled into 3D‑MTs may represent an interesting therapeutic strategy for a 
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COL  Collagen
ECM  Extracellular matrix
GAG  Glycosaminoglycan
H&E  Haematoxylin and eosin
HA  Hyaluronic acid
HIF-1α  Hypoxia-inducable factor 1α
ID  Incubation day
microCT  Microcomputed tomography
MRI  Magnetic resonance imaging
MSCs  Mesenchymal stem cells
MTs  Microtissues
NaCl  Sodium chloride
PBS  Phosphate buffered saline
PLGA  Poly-lactic-co-glycolic acid
ROI  Region of interest
SCs  Single cells
SFM  Serum-free media
TE  Tissue engineered
TEC  Tissue engineered construct
Bone tissue engineering (BTE) has been considered as a next-generation strategy to treat large bone defects. 
Whereas bone has the unique ability to self-repair minor  injuries1, large bone defects are still treated by autolo-
gous bone grafts from different origins. The iliac crest is usually preferred for this purpose, but it is associated 
with a variety of adverse  events2. As a new promising strategy, tissue engineered (TE) substitutes have gained 
a lot of attention. Although research has made much progress in BTE over the last few decades, three major 
problems still remain unresolved: (1) tissue engineered grafts do not provide the regenerative potential required, 
thus leading to a limited effectiveness to treat bone  defects3, (2) cell death in the core of the TEC because vessels 
just reach the outer shell of the  scaffolds4,5 (3) cell retention is still limited and needs to be improved, as cells 
are getting lost during  implantation6. Therefore, to achieve sufficient tissue regeneration in a TE bone graft, the 
selection of an appropriate cell type and format together with an appropriate biomaterial is crucial to enable 
in vivo performance.
Adipose tissue-derived mesenchymal stem cells (ASCs) became a popular alternative to bone marrow-derived 
mesenchymal stem cells (MSCs) as an autologous stem cell source for their minimal invasive accessibility by lipo-
suction, high yields of cells and due to easy differentiation towards the osteoblast and chondrocyte  phenotypes7–9. 
In an immunodeficient rat femur nonunion fractur model, ASCs have demonstrated improved therapeutic 
efficacy compared to human fibroblasts. Fracture healing was associated with enhanced biomechanical function 
and upregulation of bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF) and 
angiopoietin-1 in peri-fracture  tissue10. In addition to the preclinical stage, these stem cells were also applied in 
the clinical setting. In two different groups of patients with bone nonunions due to congenital pseudoarthrosis 
and bone tumours, respectively, ASCs were used to cure bone defects under extreme clinical and pathophysi-
ological conditions. Autologous ASCs were supplemented with demineralised bone matrix in order to pre-
serve the scaffold-free osteogenic 3D structure as conventional treatment was not feasible in these patients. The 
therapy led to restoration of bone anatomy and function with minor donor site morbidity and no oncological 
side  effects11. Besides the cell-based therapy approach, the secretome of MSCs offers a cell-free alternative and 
contains a cocktail of many different factors, such as growth factors and cytokines. The paracrine components 
are responsible for the angiogenic potential, the anti-inflammatory effect and therefore also for improved bone 
regeneration in vivo12–17. Similar promising results were observed with the application of secretome in clinical 
 trials18,19. This cell-free approach has the advantage of being available any time compared to the cell product itself 
and can consequently be used off-the-shelf.
Recent studies have shown that, in contrast to cell type, cell format also plays an important role in the dif-
ferentiation potential of stem cells, such as three-dimensional microtissues (3D-MTs), which are an aggregated 
format of single cells (SCs)20,21. They seem to have superior function compared to single cell applications because 
they provide an in vivo-like microenvironment to proliferate, differentiate and secret bioactive factors. Finally, 
they are protected from inflammatory reactions right after implantation and may therefore enhance therapeutic 
 efficacy22,23. In terms of the angiogenetic potential of 3D-MTs, which is one of the key factors of cell survival 
and bone formation (Fig. 1), a recent in vitro study showed that that the formation of human cardiopoietic stem 
cells into 3D-MTs substantially increases their overall angiogenic potential and functional neovascularization 
 capacity24. Furthermore, MSC-based 3D-MTs with incorporated calcium phosphate microparticles significantly 
promoted blood vessel reconstruction and bone formation 8 weeks after transplantation into a critical-sized 
defect rat  model25. The process of mineralization of hard collagenous tissue is influenced by amorphous calcium 
phosphate (a-CaP), non-collagenous proteins and collagen (COL)  itself26. The a-CaP particles act as a precursor 
of the thermodynamically more stable  hydroxyapatite27, which is the most abundant inorganic mineral present 
in  bone28–33. Collagen plays an active rather than passive role in the mineralization process by integrating the 
a-CaP into the collagen fibrils and transforming them into  hydroxyapatite34. Collagen scaffolds are osteoinduc-
tive throughout their composition and are able to bind non-collagenous proteins, which further supports the 
mineralization  process35. A recent study in a critical size bone defect in a rat model reported improved bone 
healing when using a titanium implant with collagen and glycosaminoglycan (GAG) coating versus a mere 
collagen coated  plate36. In addition to the key factors of the extracellular matrix (ECM), we showed previously 
3
Vol.:(0123456789)
Scientific Reports |         (2021) 11:5418  | https://doi.org/10.1038/s41598-021-84123-x
www.nature.com/scientificreports/
in vitro how osteogenic marker expression of human ASCs in an osteochondral interface (electrospun meshes 
of poly-lactic-co-glycolic acid; PLGA) depends on the amount of incorporated a-CaP  nanoparticles37.
Hence, the chick chorioallantoic membrane (CAM) assay offers an elegant alternative with numerous advan-
tages over rodent animal experiments such as cost effectiveness, the ease of use and its accessibility to the 
complete circulatory  system38. We and others have recently shown that the CAM assay represents an efficient 
preclinical model to assess angiogenic potential in the context of cell therapy or biomaterials  research24,39, but 
has also been used to study graft  transplantation40. Recently, it was also implemented in BTE. Using micro-
computed tomography (microCT), Moreno-Jiménez et al. showed that applying human bone cylinders from the 
femoral head on the CAM assay exhibited significantly more regenerated bone when compared to the control or 
an in vitro  group41. The CAM model is an excellent method to study the mineralization capacity of BTE and 
bone  allografts41–43. The calcium required for this process is provided by the eggshell. The allantois is located 
immediately below the porous shell and is involved in the mobilization of calcium for the skeletal formation 
of the bones of the developing  embryo44–46. Tuan et al. found a close correlation between the differentiation of 
the CAM and the embryonic ossification, suggesting that the CAM is the regulatory site for calcium transport 
via the circulatory  system47. Therefore, this condition offers an excellent opportunity to test biomaterials and 
bone grafts preclinically on an adequate blood supply for the delivery of oxygen, nutrients, progenitor cells and 
calcium. Only a viable and functional graft is able to promote bone healing.
In this study, we comprehensively evaluate and compare the effect of different stem cell formats (2D-SCs 
versus 3D-MTs) and their secretome on the mineralization capacity of a natural collagen scaffold. Considering 
major key factors affecting bone regeneration, a detailed evaluation was performed using the in ovo CAM assay 
model system. To provide a more in-depth understanding of the mineralization process, additional cell infiltra-
tion, neovascularization, glycosaminoglycan and collagen formation were investigated. These are relevant factors 
they ensure the integrity and viability of the scaffold and, through the ECM, influence bone formation and the 
mineralization process itself. The assessment was based on 2D-histological analysis and microCT determina-
tion to bring the mineralized scaffold into a three-dimensional context. The specific hypotheses were that (1) 
3D-MTs enhance scaffold calcification and vessel ingrowth compared with 2D-single cells, (2) the secretome of 
3D-MTs promotes calcification and vessel ingrowth more than the one secreted from 2D-single cells, and (3) 
the secretome is as potent as the corresponding cells from which it was harvested with respect to vessel ingrowth 
and calcification capacity.
Results
Time course to analyze the occurrence of key factors which influence and enhance mineraliza‑
tion capacity. The feasibility and potential of mineralization of a collagen scaffold in ovo was investigated by 
a time course experiment. The scaffolds were soaked with physiological phosphate buffered saline (PBS) solution 
and incubated for 1 week on the CAM. On day 1, 3, 5 and 7 of incubation, a histological analysis was performed. 
In order to obtain a more precise indication in which zone of the scaffold the initial processes occur and how 
they can be characterized throughout the entire scaffold area, the scaffold was divided into the three regions, 
i.e. interface, middle and surface. Our analysis showed that cell infiltration (Fig. 2A) and blood vessel ingrowth 
(Fig. 2B) started instantly after incubation. On day 1 a cell infiltration area fraction of 30.19 ± 6.84% (Mean ± SE) 
and a vessel density of 10.23 ± 4.57 vessels/mm2 were detected and had spread over 7 days towards the surface 
region with 36.60 ± 14.99% and 10.70 ± 13.46 vessels/mm2. Within a week of incubation, the infiltration rate and 
Figure 1.  Key factors for bone regeneration in the applications of bone grafts in combination with stem 
cells or their secreted factors. In addition to calcification, components of the extracellular matrix such as 
glycosaminoglycan (GAG) and collagen play an important role in the healing process. For the functionality of 
the bone and the viability of the graft, the enabling of cell infiltration and thus vascularization of the construct 
are also important prerequisites. The selection of an appropriate biomaterial as scaffold is of fundamental 
relevance, as this must be able the interaction of the key factors mentioned above. When combined with stem 
cells or their secretomes only, the regeneration is further promoted by paracrine factors.
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vessel density were increased significantly in the interface region to a maximum amount of 63 ± 15.39% and 
43.54 ± 17.63 vessels/mm2 and respectively (Fig. 2A,B).
After 3 days of incubation a distinct increase in the collagen (Fig. 2C) and glycosaminoglycan (Fig. 2D) forma-
tion was observed, predominantly in the interface region (43.38 ± 17.90% for COL; 5.22 ± 7.13% for GAG) with 
a decreasing content towards the surface region (30.40 ± 19.18% for COL; 3.74 ± 7.86% for GAG). Once more 
comparing day 1 and day 7 with each other in both different tissues analyzed, the interface, middle and total area 
had shown a significance difference over time. The mineralization process (Fig. 2E,F) had increased significantly 
after day 5 and was mainly detected in the surface region. On day 7, the amount of total mineralization was 
significantly higher than over all previously measured time points within the respective region.
Taken together the time course illustrated the sequence in which the individual key factors develop (Supple-
mentary Fig. S1). Mineralization was present in the surface region from day 5 onwards. In contrast, cell infiltra-
tion and blood vessel ingrowth in the interface region began instantly after incubation on the CAM, followed 
by collagen and GAG formation on day 3.
Influence of stem cell format on cell infiltration, cell density and vascularization of collagen 
scaffold. Corresponding to the time course, cell and tissue infiltration as well as the formation on neo-
vessels, starting already at day 1 after incubation from the interface region and spreading up to the surface 
region over time, the influence of the different stem cell formats, 2D-SCs vs 3D-MTs, and their corresponding 
secretome was analysed (Fig. 3). At day 7, cross sections were stained with haematoxylin and eosin staining 
(H&E; Fig. 3E–L) and the area fraction (%) as well as cell and vessel densities were assessed.
Focusing on differences across the entire scaffold between the four experimental groups with respect to tissue 
infiltration (Fig. 3A), only 2D-SCs group (63.90 ± 8.65%) showed improvement a higher infiltration rate com-
pared to the 3D-MTs (49.88 ± 6.87%). The cell density (Fig. 3C) did not differ significantly between the groups.
Within one scaffold between the three different region of interests (ROIs), the interface region of was 
mostly affected in terms of cell infiltration (Fig. 3B,E–H) and cell density (Fig. 3C,E–H) with a decline in their 
content to the upper regions. Exceptionally therefore was the infiltration capacity of 2D-SCs (Fig. 3E), which 
interestingly showed a homogenous distribution over the entire scaffold (interface: 67.25 ± 9.04%, middle: 
62.32 ± 10.76%, surface: 62.14 ± 8.19%). A similar pattern was also found in the 3D-MTs group, but with signifi-
cantly less pronounced area fractions. This homogenous distribution in the 2D-SCs group with high contents 
of tissue infiltration up to the top of the scaffold led in the inter-group comparison (Fig. 3B) to superiority of 
the surface region of 2D-SCs (62.14 ± 8.19%) compared to its secretome (36.20 ± 15.31%) and to the 3D-MTs 
(48.85 ± 9.51%). Similar findings were made regarding cell density (Fig. 3D) where in the middle region 2D-SCs 
(1797.64 ± 540.11 cells/mm2) were superior compared to 3D-MTs (1057.42 ± 582.30 cells/mm2) and in the surface 
Figure 2.  Time course regarding the occurrence and impact of key factors on the calcification process analyzed 
in collagen scaffold. The timing of the various factors involved was investigated (A–F) using the CAM assay. A 
marked increase in cell infiltration and vessel density in the scaffold was observed on day 1 (A, B). On day 3, 
there was a distinct increase in collagen and glycosaminoglycan (GAG) content (C, D) and from day 5 on, an 
accumulation of calcium deposits could be sufficiently detected (E), which could also be shown by microCT 
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Figure 3.  Histological analysis of cell infiltration (%) and cell density (cells/mm2) into the natural collagen 
scaffold (Optimaix). Histological analysis of the infiltration (A, B), cell density (C, D) and vessel density (M, 
N) of the four cultivation groups are assessed on day 7. Results are presented in a group comparison of the 
total scaffold (A, C, M) and more specified in differing three ROIs (interface (I = red), middle (M = yellow) and 
the surface (S = blue)) shown in (B, D, N). Significances of intra-group calculations are demonstrated within 
the graph whereas inter-group differences with its corresponding ROIs are listed on the separate table next to 
the graph (B, D, N). The results are illustrated with an exemplary out-take of each experimental group using 
single cells (E, I), 2D-SCs secretome (F, J), 3D-microtissues (G, K), 3D-MT secretome (H, L). The scale bar 
was defined with 400 µm in the overview examples (E–H) and 50 µm for the more detailed examples (I–L). 
Statistical results were established with a one-way ANOVA considering only one independent factor and a two-
way ANOVA considering two categorical factors and the effect of the categorical factors on each other. P-values 
were considered significant by the APA-System: 0.12 (ns), 0.033 (*), 0.002 (**), < 0.001 (***).
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region (2090.76 ± 701.01 cells/mm2) had an advantage compared to the 3D-MTs (1285.61 ± 479.39 cells/mm2) 
and its secretome group (1564.66 ± 1088.91 cells/mm2).
Comparing vessel density of the entire scaffold (Fig. 3M) between all four groups, highest numbers were 
counted in the 2D-secretome group (26.64 ± 6.42 vessels/mm2) by trend. The highest neo-vessel development was 
found in the interface to the connecting CAM (Fig. 3N), with values between 30 and 40 vessels/mm2. Vasculariza-
tion into the middle region was interestingly most prominent in the 2D-SCs secretome group (29.99 ± 7.72 ves-
sels/mm2) and was even better than found for cell-seeded 2D-SCs.
Briefly, our data suggest that tissue infiltration and cell density go along closely, and the interface was the 
predominantly affected region with highest contents in the 2D-SC group. In terms of vascularisation, however, 
the 2D-SC secretome group was able to induce the most vessels up to the middle region and was superior com-
pared to its cell-seeded counterpart.
Collagen and glycosaminoglycan formation. It is well known that collagen and glycosaminoglycan 
play an active role in bone  formation34–36. Therefore, we had histologically analysed a collagen scaffold with either 
a cell-based cultivation using 2D-SCs and 3-MTs or a cell-free cultivation using their corresponding secretome 
regarding COL-formation with a Masson-Goldner-Trichrome stain or GAG-formation with an Alcian Blue 
stain respectively. As a reference to what amount of positive staining is caused by the fibers of the scaffold itself, 
a cell-free version of the scaffold was cultured and analyzed (Fig. 4).
Starting with the five different experimental groups and their effect over the entire scaffold (Fig. 4A,K), it 
appeared that every group except the 2D-SCs secretome group was significantly more positively stained as the 
reference group (10.14 ± 5.00%). The 2D-SCs-based scaffold contained significantly more collagen (53.22 ± 9.79%) 
than its corresponding secretome (30.96 ± 11.38%) and 3D-MTs (34.67 ± 14.35%; Fig. 4A). However, GAG pro-
duction was thereby not affected (Fig. 4K). Although no significant changes in GAG production could be detected 
in relation to the overall scaffold, a detailed analysis was performed, dividing the scaffold into the three regions 
of interest, the interface, the middle and the surface. These regions were compared within the same group 
(Fig. 4B,L) for COL and GAG, respectively. In general, cell-seeded approaches had a COL and GAG content 
that was more homogenous (Fig. 4C,E,M,O), whereas their secretome counterparts presented a stepwise decline 
towards the surface (Fig. 4D,F,N,P). This finding led to significant more COL formation in the interface compared 
to their surface region of the 2D-SCs secretome (48.42 ± 17.97% vs. 16.67 ± 4.03%) and the 3D-MTs secretome 
group (54.41 ± 9.40% vs. 25.08 ± 10.82%; Fig. 4B). Same observation was made in the 3D-MT secretome group 
(30.93 ± 12.11% vs. 9.24 ± 5.49%) for the GAG formation (Fig. 4L).
The fact that COL has its highest yields in the 2D-SCs experimental group (middle: 51.97 ± 9.88%, surface: 
55.03 ± 8.82%) was confirmed by significant differences compared to the middle region and surface region of 
their corresponding secretome and the 3D-MT group (Fig. 4B). Similar findings were made when compared the 
surface region of GAG formation between 2D-SCs (19.90 ± 7.38%) and their cell-free approach (6.61 ± 6.58%; 
Fig. 4L).
In summary, our results show that the distribution of both collagen and glycosaminoglycan demonstrated a 
quite similar and homogenous distribution in 2D-SC und 3D-MT groups, while the cell-free approaches were 
associated with a decrease in content up to the surface region. Highest ECM contents were produced of the 
2D-SC group regarding COL formation and less pronounced in GAG formation.
Mineralization potential of a collagen scaffold combined with stem cells or its secretome. Min-
eralization capacity was evaluated with two different quantitative methods. Firstly, calcium phosphate was histo-
logically detected with Von Kossa staining (Fig. 5A–J) which was followed by the assessment of the mineralized 
area fraction of total scaffold determined by microCT analysis (Fig. 5K–O).
A two-dimensional histological analysis showed that the mineralization potential did not differ significantly 
between the four experimental groups with respect to the overall scaffold (Fig. 5A). The 3D-MTs group hat the 
highest amount of mineralization deposits (5.93 ± 3.14%) and there was a trend in favour of both 3D-MT groups. 
Splitting the scaffolds into three ROIs (Fig. 5B), the surface region was mostly mineralized in all experimental 
groups compared to the other regions. Furthermore, the 3D-MTs showed the highest yields in the surface region, 
even significantly higher compared to the 2D-SCs. The comparison of their corresponding secretome with each 
other had shown comparable effects. Specifically, the 3D-MT secretome showed significantly more detectable 
mineralization deposits than its 2D-SC counterpart (4.11 ± 1.04% vs. 2.52 ± 0.68%).
Interestingly, the 3D-MT secretome group (1.98 ± 0.38%) was superior to the all other experimental groups 
in case of microCT analysis (Fig. 5K–O) with respect to mineralization deposits. The other remaining groups 
such as 2D-SC (0.56 ± 0.44%), the 3D-MT (0.58 ± 0.37%) and the 2D-SC secretome (0.89 ± 0.19%) therefore 
showed lower values. A 7 day in vitro cultivation of the scaffold with 2D-SCs showed no signs of mineralization, 
neither by histological analysis nor by microCT (Fig. 5K). Interestingly, mineralization in cell-based cultures 
(Fig. 5L,N) were mainly observed in the surface area, where secretome-based cultures mineralized more diffusely 
throughout the scaffold (Fig. 5M,O).
After the incubation on the CAM (Fig. 5P), the surface of the collagen scaffolds were additionally examined 
under the microscope. It was found that on day 7 the mineralization extent could already be estimated in the 
different regions without quantitative analysis (Fig. 5Q–T).
Taken together, in a 2D-histological analysis mineralization was found the most in the 3D-MT group pre-
dominantly in the surface region and was superior to the 2D-SC group. Analysing the scaffold using microCT 
showed more diffuse enhancement in the 3D-MT secretome group than the cell-seeded counterpart and stood 
out when using a three-dimensional analysis method.
7
Vol.:(0123456789)
Scientific Reports |         (2021) 11:5418  | https://doi.org/10.1038/s41598-021-84123-x
www.nature.com/scientificreports/
Discussion
Bone tissue engineering still faces major challenges, such as donor site morbidity, limited availability and poor 
vascularization. The ultimate goal is to deliver a viable and qualitative high-end bone substitutes for the treatment 
of large bone defects which may overcome the standard of  care48. To promote the regeneration process, stem 
cells may have a beneficial impact by secreting bioactive molecules (paracrine effects). Hence, next-generation 
therapeutic concepts should combine state-of-the-art biomaterials and stem cells with a particular focus on the 
appropriate format.
In our study, we used a scaffold-based approach and human ASCs to investigate the influence of 3D-micro-
tissues in comparison to common 2D-single cells and their corresponding secretomes, on several key factors 
regarding the osteoconductive potential in bone formation (Fig. 6)49. A commercially available porcine collagen 
scaffold,  Optimaix24,39, already known in bone  regeneration50, was used as a biomaterial. It was combined with 
the different approaches (Fig. 7) and applied in the CAM assay. Afterwards histological analysis with respect to 
cell infiltration, vascularization potential, collagen and glycosaminoglycan formation and mineralization poten-
tial of the combined biomaterial stem cell bone graft was performed. In parallel, microCT analysis was used as 
a second objective method to quantify mineralization of the scaffolds. Following the chronological sequence 
shown in Fig. 2, the different changes in the scaffold over the 7 days of incubation are discussed in detail with 
regard to bone forming key factors (Fig. 6).
Figure 4.  Histological analysis of collagen and glycosaminoglycan formation into the natural collagen scaffold 
(Optimaix). Histological analysis of collagen (A–J) and GAG (K–T) of the four cultivation groups are assessed 
on day 7. An additional scaffold only group was assessed to provide a reference what amount is stained by 
the scaffold itself. Results are presented in a group comparison of the total scaffold (A, K) and more specified 
in differing three ROIs (interface (I), middle (M) and the surface (S)) (B, L). Significances of intra-group 
calculations are demonstrated within the graph whereas inter-group differences with its corresponding ROIs are 
shown on the separate tables. The results are illustrated with an exemplary out-take of each cultivation group 
using single-cells (C, G, M, Q), 2D-SCs-secretome (D, H, N, R), 3D-microtissues (E, I, O, S), 3D-MT-Secretome 
(F, J, P, T). An exemplary part of the interface region is shown for each group (G–J, Q–T). The scale bar was 
defined with 400 µm in the overview examples (C–F, M–P) in both stains and 100 µm for the more detailed 
examples of collagen formation (G–J) and 50 µm of GAG formation (Q–T). Statistical results were established 
with a one-way ANOVA considering only one independent factor and a two-way ANOVA considering two 
categorical factors and the effect of the categorical factors on each other. P-values were considered significant by 
the APA-System: 0.12 (ns), 0.033 (*), 0.002 (**), < 0.001 (***).
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At day 1 of incubation on the CAM, tissue infiltration and neovascularization started to develop from the 
interface region to the surface (Fig. 2A,B). A fast tissue infiltration and high cell densities are the key factors for 
integration of the scaffold into the transplanted  site51,52. Modulation of this effect can be achieved by varying the 
pore  size53–55, the  stiffness56–58 or the surface  composition59. Even if pore sizes between 100 and 150 μm are pre-
ferred in terms of bone formation, smaller pores as found in our scaffold still can build  osteoid54. Considering the 
use of biodegradable material suggests that this osteoid will transform into bony tissue while the whole collagen 
scaffold is resorbed. Results in this study demonstrated that 2D-SCs promoted higher infiltration throughout the 
chosen collagen scaffold than 3D-MTs. Infiltrated cells could consist of mesenchymal origin, such as  fibroblasts24.
Furthermore, sufficient vascularization remains a major problem, affecting the viability of the scaffold in the 
long term. Every tissue with a greater diameter than 100 μm limits the range of oxygen and nutrition supply to 
mere diffusion and depends on a newly formed vascular system if central core necrosis wants to be  prevented4,60. 
The importance of a highly functional vascular system is not only necessary for the viability of the scaffold itself, 
but also to enhance osteogenesis  directly61,62. Therefore, VEGF plays a double role, both in promoting endothelial 
cell migration and proliferation and in stimulating osteogenesis by the regulation of osteogenic growth  factors63. 
It is known that microtissues can enhance VEGF production size-dependently by inducing hypoxia-inducible 
factor 1α (HIF-1α) by its hypoxic  core64. In our study, vessel density was highest only by trend in the 2D-SCs 
secretome group over the whole scaffold (Fig. 3M). More detailed analysis revealed that neovascularization 
mostly took place from the interface region with a decline in vessel density towards the surface region (Fig. 3N). 
Figure 5.  Histological and microCT analysis of the calcification potential of ASCs in the natural collagen 
scaffold (Optimaix). Calcification was assessed with Von Kossa histological analysis (A–J) and a microCT 
analysis (K–O). Results are presented in a group comparison of the total scaffold (A, K) and more specified 
in differing three ROIs (interface (I), middle (M) and the surface (S); shown in B). Significance of intra-group 
calculations are demonstrated within the graph whereas inter-group differences with its corresponding ROIs 
are shown on the separate table, bellow the graph (B). The results are illustrated with an exemplary out-take of 
each cultivation group using single-cells (C, G, L, Q), 2D-SCs secretome (D, H, M, R), 3D-microtissues (E, I, 
N, S), 3D-MT secretome (F, J, O, T). An exemplary part of the surface region is shown for each group (G–J). 
Two scaffolds were placed as onplants on the CAM of each chicken egg (P). View of the scaffolds from the top 
shows a tendency of calcification (Q–T). Dotted line marks edge of scaffolds. The scale bar was defined with 
400 µm in the overview examples (C–F) and 50 µm for the more detailed examples (G–J). Statistical results 
were established with a one-way ANOVA considering only one independent factor and a two-way ANOVA 
considering two categorical factors and the effect of the categorical factors on each other. P-values were 
considered significant by the APA-System: 0.12 (ns), 0.033 (*), 0.002 (**), < 0.001 (***).
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Vessels in the 2D-SC secretome group, however, were newly formed predominantly in the middle region and were 
significantly different compared to 2D-SCs only. Considering these findings, its secretome was just as potent as 
the cell-based cultivation itself. These can be explained by the paracrine factors influencing neovascularization 
to a high  degree65,66.
Glycosaminoglycans (GAGs) have become a powerful tool in TE the last years and drew attention for the crea-
tion of new  biomaterials67–69. They provide biocompatible, biodegradable and non-immunogenic properties that 
Figure 6.  Heat map showing overview of key results. All quantitative results were assigned to one of the 
following categories zero, low, medium and high and color-coded accordingly. The investigated scaffolds of the four 
experimental groups 2D-single cells (2D-SCs), 3D-microtissues (3D-MTs) and corresponding secretomes were 
either analyzed as an entire scaffold (Total) or one of the three regions interface (I), middle (M) and surface (S).
Figure 7.  Schematic experimental setup for the investigation of calcification capacity of Optimaix scaffold 
in combination with human adipose tissue-derived mesenchymal stem cells or secretome. After isolation of 
human ASCs, the cells are cultured either as 2D -single cells or as 3D-microtissues. Afterwards, they are seeded 
onto collagen scaffolds. The secretomes of both cell formats are also added to separate scaffolds. After incubation 
of the scaffolds on the CAM, microCT analysis is performed to determine the degree of calcification and 
followed by a comprehensive histological assessment.
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have made GAGs useful in clinical  applications70. Hyaluronic acid (HA), the simplest GAG and one of the major 
components in the ECM, affects proliferation, differentiation and cell migration under in vitro  conditions71–76. 
Many studies have shown significant improvement in bone formation by applying HA to different filler materials, 
such as octacalcium phosphate granules, MegaGen synthetic bone or carbon nanotubes—even without the use of 
growth  factors77,78. De Brito Bezerra et al. for example applied a HA gel (1%) in combination with an absorbable 
collagen sponge in a 5 mm critical size defect in rats and demonstrated that bone healing with HA was superior 
to the collagen sponge  only79.
Regarding GAG formation over the entire scaffold, no significant difference between the four experimental 
groups could be distinguished in our study (Fig. 4K). In contrast to our expectation, the cell-based groups 
induced more homogenous GAG production with relatively equal contents in each zone, whereas both secretome 
groups showed a constant decline from the interface to the surface region. Against the assumption that secretome 
might diffuse more easily through the scaffold and therefore evoke GAG production evenly up to the surface, 
we found this effect only for the cell-based groups. However, a comparison to the results of tissue infiltration 
and cell density supports the findings for GAGs because similar trends were found. In other words, only where 
enough tissue infiltration with a high enough cellular density is provided ECM components can be formed. In 
addition, the stem cells secrete paracrine factors in a continuous way from the surface and thus can stimulate 
infiltration and ECM formation equally in all regions.
Collagen has also major relevance in the formation of new bone, by integration of amorphous calcium phos-
phate into the fibrils and transforming it into  hydroxyapatite34,35. Moreover, osteoblastic cells produce a complex 
ECM which is composed of proteoglycans, collagens and non-collagens. The interplay between proteoglycans 
with matrix effector molecules such as the chains of GAGs or their core protein is essential for regulating a variety 
of cellular  processes75. Collagen formation was supported particularly by 2D-SCs in our study, with significantly 
higher yields than found for its corresponding secretome or the 3D-MT groups (Fig. 4A). Cell-based experimen-
tal groups showed a more homogenous COL production than their secretomes, like found for GAGs (Fig. 4F).
Many studies have shown an excellent vascularization potential and efficiency of scaffolds using the CAM 
assay, which suggests to use it as an convenient model to test biomaterials and bone  allografts80,81. However, there 
are only a few studies regarding their calcification  potential41–43. In our comparison of whether bone formation 
is enhanced in one of the two cell formats, we were able to demonstrate that in a histological analysis 3D-MTs 
showed more mineralization. This either by a trend regarding the entire scaffold or by a significance mainly in 
the surface region where the mineralization phases were always primarily deposited. In a previous study, similar 
results were obtained by seeding ASC-based 3D-MTs and 2D-SCs on electrospun nanocomposites in vitro. Under 
static conditions, osteogenic and angiogenic markers increased in the 3D-MT group compared to the 2D-SC 
 group82. Similar findings were made when ASCs where incorporated in a mineralized spheroid composite and 
were cultured in vitro without osteogenic supplement medium. Twenty times higher RUNX2 gene expression 
was found compared to the no mineral fiber  group83. The question arises whether the stem cells themselves or 
their secretome alone should be used in combination with the collagen scaffold to best support mineralization. 
The cell-based cultures are more influenced by their autocrine  factors84 mineralizing their ultimate vicinity, 
while their corresponding secretome diffuses more into the scaffold acting via paracrine factors and probably 
influencing stem cells originated from the chicken embryos.
There were no significant differences in our study between the cell-based groups and their corresponding 
secretome (Fig. 5A,F), indicating that there was no superiority. In contrast, the microCT results (Fig. 5K–O) 
showed a clear difference in the mineralization pattern within the scaffold and between the experimental groups. 
Both secretome groups showed a more diffuse and homogeneous mineralization throughout the scaffold and 
were increasingly detectable not only in the surface region. The area fraction of mineralization deposits in the 
3D-MT secretome group was clearly superior to all other groups. We conclude that the 3D-MT secretome is the 
favorite regarding an optimum mineralization here.
In future studies, we need to investigate the effect and the composition of the 3D-MT secretome in more depth 
(proteomics) and propose it as convenient alternative to cell-based treatment. The advantage of a “off-the shelf ” 
secretome is its readiness and long-term preservation—two aspects that might otherwise pose problems in cell 
therapies. The next step is the implementation into a rodent in vivo model to perform a long-term study of the 
tested biomaterial combined with 3D-MT secretome in a bone defect. Here, the regeneration and remodeling 
processes are expected to be more pronounced due to additional mechanical and biochemical  stimulus85–87. In 
addition, it will allow to further investigate the paracrine effects of the 3D-MT secretome in relation to the bone 
healing process.
Our study has a several limitations: first, the CAM assay is restricted to 7 days, which limits the time avail-
able for the examination. Second, mineralization deposits were detected with a Von Kossa stain which did not 
differ in which phase calcium is present on a molecular  level88. Third, histological slides allow analyses in a 
two-dimensional manner and only allow extrapolations to be made about the entire scaffold. Fourth, in order 
to characterize the infiltration of individual cell types and to perform further comprehensive histological analy-
ses, addressing differentiation processes of stem cells and the presence of osteogenic cells, specific antibodies 
are rare if not unavailable for the chicken species. Finally, whenever possible, PCR technique may be used for 
further characterization and quantification of specific markers, as far as chicken-specific primer sequences are 
known and available.
In summary, we here evaluated a biodegradable collagen-based scaffold which was either seeded with 
human MSCs as single cells or as 3D-microtissues and compared to the scaffold soaked with the correspond-
ing secretomes. The results confirmed in all experimental groups an accumulation of collagen and GAG in 
the scaffold over time, as well as a pronounced cell infiltration and vascularization. All conditions showed an 
osteoconductive potential, whereas the soaking with secretome of 3D-microtissues was superior in regard to 
mineralization capacity showing a more homogeneous distribution of mineralization deposits within the scaffold 
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and it also promoted cell infiltration from host tissue. In addition, it is simple to preserve, and its instant readiness 
makes it a good off-the-shelf candidate. Therefore, the secretome of MSCs combined with a collagen scaffold may 
be considered as an interesting approach for a cell-free next-generation functional bone graft.
Methods
Study design. Human mesenchymal stem cells were isolated from lipoaspirate material. The cells were then 
cultivated either as single cells or in hanging drops as 3D-microtissues. After 3 days, both the cells and their 
corresponding secretome were harvested. Collagen-based Optimaix scaffolds were seeded with either 2D-SCs, 
3D-MTs or corresponding secretomes and incubated on the CAM for 7 days. For the detection and quanti-
fication of mineralization deposits, the scaffolds were examined by microCT and then processed further for 
histological analysis. A comprehensive quantitative analysis of all relevant key factors (Fig. 1) was thus achieved 
(Fig. 7). All experimental protocols were approved by the Canton Zurich ethical committee (KEK-ZH-Nr. 2010-
0476/0), Switzerland. Informed consent of patients was obtained for the isolation of ASCs from lipoaspirate.
Cell culture. Human ASCs (n = 3) were isolated from lipoaspirate after obtaining the written patient’s con-
sent. All protocols were conducted in accordance to the Cantonal Ethics Committee Zurich in Switzerland 
(KEK-ZH-Nr. 2010-0476/0). Cells were processed and cultivated as described  elsewhere89. Human ASC-based 
3D-MTs were generated using the hanging drop  method90. For this purpose, 10,000 cells/ml were seeded into 
Terasaki microtest plates (Greiner Bio-one, Germany). Drop sizes with a volume of 25 μl were incubated upside 
down under standard conditions for 3 days. Both the harvested 3D-MTs and the 2D-SCs were washed with 
phosphate buffered saline (PBS; Sigma Aldrich, Switzerland) and resuspended in 30  μl serum-free medium 
(SFM) for seeding onto the scaffold. To prepare the conditioned medium, 2D-SCs as well as 3D-MTs were 
cultivated in a concentration of 10,000 cells/ml in SFM (DMEM high glucose, Sigma Aldrich, Switzerland) for 
3 days. The supernatant was then harvested as secretome and followed by removal of cell components using a 
centrifugation step.
Scaffolds. Optimaix (Matricel GmbH, Herzogenrath, Germany) is a porcine collagen sponge, which is bio-
degradable in vivo. The scaffolds had a size of 5 mm in diameter and 3 mm in height and contained highly 
oriented pores of 80–100 μm. This guiding structure allows the infiltration of host cells and newly formed blood 
vessels.
For cell seeding, either 500,000 cells were applied as 2D-SCs or 3D-MTs in 30 μl SFM per side of scaffold 
or the scaffold was soaked with 30 μl secretome per side (top and bottom). For the time course experiment the 
scaffolds were soaked with 30 μl PBS per side.
CAM assay. The CAM assay was performed as described  elsewhere24, using fertilized Lohmann white LSL 
chick eggs (Animalco AG Geflügelzucht, Switzerland). No IACUC approval is required until embryonic day 14 
according to Swiss animal care guidelines (TSchV, Art. 112). Briefly, on incubation day (ID) 3.5 a windowing of 
the eggshell was carried out. All incubation steps were performed at 37 °C and 65% relative humidity. On ID 7, 
Optimaix scaffolds seeded with either 3D-MTs, 2D-SCs or with the respective secretomes, were carefully placed 
on top of the CAM, two scaffolds onto each egg (Fig. 5P). The eggs were then incubated for another 7 days. For 
the time course study the eggs were incubated until ID 8, 10, 12 and 14.
Microcomputed tomography and analysis. The scaffolds fixed with 4% phosphate-buffered formalin 
solution (Formafix, Switzerland) were scanned using microCT Skyscan 1176 device (Bruker BioSpin AG, Fäl-
landen ZH, Switzerland). The scanning conditions were as follows: isotropic nominal resolution of 18 µm, 50 kV, 
500 µA, exposure of 280 ms, and two-fold frame averaging. All data was processed using manufacturer’s software 
and ImageJ (version 1.50i) software. The images were changed into an 8-bit format and then a Z projection was 
made. Thresholds were determined to a value, which suppressed all the background activity.
Histology and analysis. Paraffin embedded and with 4% phosphate-buffered formalin solution fixed scaf-
folds (between n = 3 and n = 13 per group) were sagitally bisected and from there a 5 μm section with the three 
zones (interface, middle, surface) was examined in more detail. A staining with Hematoxylin (Artechemis, Swit-
zerland) and Eosin (Waldeck, Germany; H&E) was performed to quantify cell infiltration, cell density and vessel 
density. To verify the mineralization and ECM contents of the scaffold, a staining with Von Kossa (5% silver 
nitrate solution (Roth, Switzerland), 5% sodium thiosulfate (Morphisto, Germany), nuclear red (Morphisto, 
Germany)), respectively Alcian blue (3% acetic acid (Sigma Aldrich, Switzerland), alcian blue (Morphisto, Ger-
many), 0.1% nuclear fast red (Morphisto, Switzerland)) and trichrome masson blue (ponceau fuchsin (Roth, 
Switzerland), tungstophosphoric acid orange G solution (Roth, Switzerland), light green in acetic acid (Roth, 
Switzerland)) was carried out. Images were taken with a digital slide-scanner NanoZoomer using NDP.view2 
software (Hamamatsu Photonics, Japan). The scans were made with a 40× zoom which is corresponding to a 
pixel resolution of 0.230 µm. The quantitative evaluation was performed for the entire scaffold section and for 
the three zones interface, middle and surface (Fig. 7). Area fractions of the positive staining were determined 
using Image J Fiji follow the example of the concept of Chen et al.91. The channels of the plug in “Color Deconvo-
lution” were chosen dependent on the corresponding stain. The threshold for each stain was selectively chosen to 
suppress the background activity. The area fraction was determined as the quotient of the positive staining com-
pared to the whole area in percent. The cell density and vessel density were determined using QuPath  software92. 
The numbers of counted cells and vessels were standardized to the area of one  mm2.
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Statistics. Statistical analysis was performed using GraphPad Prism 8. Results were established with a one-
way ANOVA considering only one independent factor and a two-way ANOVA considering two categorical 
factors and the effect of the categorical factors on each other. P-values were considered significant by the APA-
System: 0.12 (ns), 0.033 (*), 0.002 (**), < 0.001 (***).
Data availability
All raw data and processed images generated and analysed during the current study are available from the cor-
responding author on reasonable request.
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